Oregon City, Oregon Clinical Trials

A listing of Oregon City, Oregon clinical trials actively recruiting patient volunteers.

Filter By
Clear all Advanced
I am/have/had
added new label for I am/have/had
more
I am looking for
added new label for I am looking for
more
Advanced Filters
Found 48 clinical trials
Naproxen Pharmacogenetic Study (Project 1 Aim 2)

This is a mechanism-based study in healthy adults to determine the effect of the CYP2C9 M1L gene polymorphism on the functional activity of the encoded CYP2C9 enzyme towards the probe substrate naproxen. CYP2C9 activity will be evaluated by measurement of O-desmethyl naproxen and unchanged naproxen in 24-hour urine following administration …

Oregon Health & Science University
 (9.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
A Study of Opaganib in Coronavirus Disease 2019 Pneumonia

Opaganib, a sphingosine kinase-2 (SphK2) inhibitor, has been broadly tested in Phase I/II studies. Extensive nonclinical data indicates both anti-viral and anti-inflammatory activity via selective SphK2 inhibition which may prove beneficial for treating COVID-19 infection and resulting pneumonia. This proof of concept study will take place in the US and …

pneumonia
opaganib
covid-19
x-rays
chest x-ray
Oregon Health & Science University
 (9.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +4 other locations
Durvalumab With or Without Olaparib as Maintenance Therapy After First-Line Treatment of Advanced and Recurrent Endometrial Cancer

A study to assess the efficacy and safety of durvalumab in combination with platinum-based chemotherapy (paclitaxel + carboplatin) followed by maintenance durvalumab with or without olaparib for patients with newly diagnosed advanced or recurrent endometrial cancer.

immunomodulator
cancer
durvalumab
maintenance therapy
carcinoma
Research Site
 (9.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +94 other locations
A Phase 3 Study to Evaluate Efficacy and Safety of AL001 in Frontotemporal Dementia (INFRONT-3)

A phase 3 double blind, placebo controlled study evaluating the efficacy and safety of AL001 in participants at risk for or with frontotemporal dementia due to heterozygous mutations in the progranulin gene.

progranulin
dementia
pick's disease
aphasia
Oregon Health and Science University
 (9.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +46 other locations
Study Details  

 

Portland Site
 (6.7 away)
  • 0 views
  • 16 Feb, 2024
  • 1 location
2019-06 TRISCEND Study

Early feasibility study to assess safety and performance of the Edwards EVOQUE Tricuspid Valve Replacement System

medical therapy
tricuspid valve replacement
Oregon Health & Science University
 (9.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +6 other locations
A Safety and Efficacy Study Evaluating CTX120 in Subjects With Relapsed or Refractory Multiple Myeloma

This is a single-arm, open-label, multicenter, Phase 1 study evaluating the safety and efficacy of CTX120 in subjects with relapsed or refractory multiple myeloma.

refractory multiple myeloma
multiple myeloma
Research Site 3
 (9.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +5 other locations
Testing the Addition of Radiotherapy to the Usual Treatment (Chemotherapy) for Patients With Esophageal and Gastric Cancer That Has Spread to a Limited Number of Other Places in the Body

This phase III trial studies how well the addition of radiotherapy to the usual treatment (chemotherapy) works compared to the usual treatment alone in treating patients with esophageal and gastric cancer that has spread to a limited number of other places in the body (oligometastatic disease). Radiotherapy uses high energy …

MRI
hiv test
gastric adenocarcinoma
metastatic gastric adenocarcinoma
adenocarcinoma of esophagus
Clackamas Radiation Oncology Center
 (4.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +254 other locations
Progressive Resistance Training for Sarcoma Survivors

This trial studies how well progressive resistance training works in improving the physical function of sarcoma survivors. Treatments for sarcoma can cause side effects such as fatigue, muscle loss, and weakness, which can negatively impact a patient's ability to physically function and enjoy an independent lifestyle. Engaging in a resistance …

weakness
resistance training
cancer
residual tumor
sarcoma
OHSU Knight Cancer Institute
 (9.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • 1 location
Expanded Access of Omidubicel for Allogeneic Transplantation in Patients With Hematological Malignancies

Omidubicel is an investigational therapy for patients with high-risk hematologic malignancies.

allogeneic transplantation
cancer
hematologic malignancy
investigational treatment
Oregon Health & Science University
 (9.8 away) Contact site
  • 0 views
  • 16 Feb, 2024
  • +3 other locations